SOLIGENIX, INC. Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable
SOLIGENIX, INC. (SNGX) had Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable of 6.80 million shares as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Option, Exercise Price Range, Beginning of Period
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions · last filed 2026-03-31
- 2025-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 6.80M shares.
- 2024-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 1.47M shares.
- 2021-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 3.33M shares.
- 2020-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 5.73M shares.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable |
|---|---|
| 2025-12-31 | 6.80M shares 10-K · filed 2026-03-31 |
| 2024-12-31 | 1.47M shares 10-K · filed 2025-03-21 |
| 2021-12-31 | 3.33M shares 10-K · filed 2022-03-29 |
| 2020-12-31 | 5.73M shares 10-K · filed 2021-03-30 |
| 2015-12-31 | 2.08M shares 10-K · filed 2016-03-24 |
| 2013-12-31 | 8.16M shares 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |